MK2 Is Required for Neutrophil-Derived ROS Production and Inflammatory Bowel Disease

Area of Science:

• Gastroenterology
• Immunology
• Molecular Biology

Background:

• Inflammatory bowel disease (IBD) is a chronic gastrointestinal disorder characterized by inflammation and elevated reactive oxygen species (ROS).
• The role of specific kinases, such as MAPK-activated protein kinase 2 (MK2), in modulating ROS production and IBD pathogenesis remains incompletely understood.

Purpose of the Study:

• To investigate the role of MK2 in the development of dextran sulfate sodium (DSS)-induced inflammatory bowel disease (IBD) in a mouse model.
• To determine if MK2 modulates reactive oxygen species (ROS) production in neutrophils and its contribution to IBD.

Main Methods:

• Utilized a mouse model of DSS-induced colitis, comparing wild-type (WT) mice with mice genetically deficient in MK2 specifically in myeloid lineage cells (MK2^Lyz2-KO).
• Assessed histological damage, inflammatory markers (IL-6, TNF-α), ROS generation, Ki67-positive cells, and myeloperoxidase (MPO) concentrations.
• Investigated ROS production and signaling pathways (Akt, p38 MAPK phosphorylation) in MK2-deficient neutrophils stimulated with N-formyl-methionyl-leucyl-phenylalanine (fMLF).

Main Results:

• Genetic ablation of MK2 in myeloid cells protected against DSS-induced colitis, reducing epithelial and goblet cell damage.
• MK2-deficient mice showed decreased levels of IL-6, TNF-α, ROS, Ki67-positive cells, and MPO in the intestinal epithelium.
• MK2 deficiency attenuated ROS generation in neutrophils and reduced Akt and p38 MAPK phosphorylation upon fMLF stimulation.

Conclusions:

• MK2 is essential for neutrophil-derived ROS production and plays a critical role in the pathogenesis of IBD.
• MK2 and ROS represent promising therapeutic targets for the management of inflammatory bowel disease.